Not applicableNo Longer AvailableNCT03010332
What this trial is testing
Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease
Who this might be right for
CMV ViremiaCMV Disease
Atara Biotherapeutics